Document is current
Any future updates will be listed below
-
Authors
de Mendonça, Renata Silva
Arruda Santana, Ana Beatriz
Azzoni, Andreia Braga Mota
de Almeida, Ana Luiza Viegas
Castro, Matheus Augusto Araujo
Lucato, Leandro Tavares
Kok, Fernando
de Gusmao, Claudio M.
- License Information
-
More Information
Article History
Received: 23 September 2025
Accepted: 16 November 2025
First Online: 25 November 2025
Declarations
:
: The study was conducted in accordance with the ethical standards of the Brazilian National Health Council Resolution 466/12 and the Brazilian General Data Protection Law (Law No. 13.709/2018). All authors confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.
: Written informed consent for publication, image and video recording was obtained from the patients’ parents during clinical evaluations. Verbal informed consent was obtained from the patients, as they were unable to provide written consent.
: Renata S. de Mendonca, Ana Beatriz (A) Santana, Andreia (B) M. Azzoni and Ana L. V. Almeida do not report any additional financial disclosures. Leandro Lucato is an employee of the University of Sao Paulo. Claudio M. de Gusmao was previously an employee of Mendelics Genomic Analysis until 2024; he has been a speaker for PTC therapeutics and a coinvestigator in NIH Fogarty grant R21NS139341. Fernando Kok is an employee of Mendelics Genomic Analysis and University of Sao Paulo; he is the Brazilian principal investigator of NIH Fogarty grant R21NS139341.
: The authors declare no competing interests.
